FrancophonIA/ELRC3.0 huggingface dataset:
English: • This suspension is not usually recommended for adults and children weighing 40 kg and over.
Maltese: • Normalment din is-suspensjoni ma tkunx irrakkomandata għal adulti u tfal li jiżnu 40 kg u aktar.
English: Aerobic Gram-negative micro-organisms Capnocytophaga spp.
Maltese: Mikroorganiżmi Gram-negattivi aerobiċi Spp. Capnocytophaga Eikenella corrodens
English: • Usual dose - 25 mg/3.6 mg to 45 mg/6.4 mg for each kilogram of body weight a day, given in two divided doses.
Maltese: • Doża tas-soltu - 25 mg/3.6 mg sa 45 mg/6.4 mg għal kull kilogramma ta' piż tal-ġisem kuljum,
English: Medicinal product administered
Maltese: TAL-PRODOTT MEDIĊINALI
English: {Augmentin and associated names (see Annex I) 500 mg/125 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 875 mg/125 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 1000 mg/125 mg powder for oral suspension in sachets}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 500 mg/125 mg fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 875 mg/125 mg fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 1000 mg/125 mg fi qratas għal suspensjoni orali }
English: Rare side effects that may show up in your blood tests: • low number of cells involved in bl
Maltese: Effetti sekondarji rari li jistgħu jidhru fit-testijiet tad-demm tieg • numru baxx ta' ċelluli involuti fit-tgħaqqi
English: 125 mg/31.25 mg, 250 mg/62.5 mg, 500 mg/125 mg powder for oral suspension in sachets, 50 mg/12.5 mg/ml, 125 mg/31.25 mg/5 ml, 250 mg/62.5 mg/5 ml powder for oral suspension This medicinal product contains maltodextrin (glucose).
Maltese: Trab ta' 125 mg/31.25 mg, 250 mg/62.5 mg, 500 mg/125 mg fi qratas għal suspensjoni orali, Trab għal suspensjoni orali ta' 50 mg/12.5 mg/ml, 125 mg/31.25 mg/5 ml, 250 mg/62.5 mg/5 ml Dan il-prodott mediċinali fih maltodextrin (glucose).
English: • lower dose - (particularly for infections such as skin and soft tissue infections and non-severe sinusitis): 1000 mg/125 mg two times a day.
Maltese: • doża anqas - (b'mod partikolari għal infezzjonijiet bħal ma huma dawk fil-ġilda u fittessuti rotob u sinożite mhux qawwija): 1000 mg/125 mg darbtejn kuljum.
English: Initial dose of 1000 mg/200 mg and then 500 mg/100 mg given every 24 hours
Maltese: Doża ta' 1000 mg/200 mg fil-bidu mbagħad 500 mg/100 mg mogħtija kull 24 siegħa
English: 400 mg/57 mg/5 ml powder for oral suspension (mixed fruit flavour) Augmentin 400 mg/57 mg/5 ml powder for oral suspension contains 2.5 mg of aspartame (E951) per ml, a source of phenylalanine.
Maltese: Trab ta' Augmentin għal suspensjoni orali ta' 400 mg/57 mg/5 ml fih 2.5 mg ta' aspartame (E951) f'kull ml, li huwa sors ta' phenylalanine.
English: g/6 .5 mg powder for oral suspension in sachets France - Augmentin n {MM/YYYY}.
Maltese: Trab ta' 500 mg/62.5 mg powder for oral suspension in sachets Franza - Augmentin
English: Augmentin 125 mg/31.25 mg powder for oral suspension in sachets contains 3.75 mg of aspartame (E951) per sachet, a source of phenylalanine.
Maltese: Trab ta' 125 mg/31.25 mg Augmentin fi qratas għal suspensjoni orali fih 3.75 mg ta' aspartame (E951) f'kull qartas, li huwa sors ta' phenylalanine.
English: PK/PD relationship
Maltese: ibnek/bintek.
English: There is no experience with Augmentin suspension in adults and children  40 kg, and therefore no dose recommendation can be given.
Maltese: M'hemmx esperjenza b'suspensjoni ta' Augmentin fl-adulti u t-tfal  40 kg, u għalhekk l-ebda rakkomandazzjoni għad-doża ma tista' tingħata.
English: • severe reduction i
Maltese: GĦAMLA KWALITATTIVA
English: Renal impairment
Maltese: Agranuloċitosi riversibbli
English: This Augmentin powder for solution for injection or infusion provides a total daily dose of up to 6000 mg amoxicillin and 600 mg clavulanic acid when administered as recommended below.
Maltese: Din il-formulazzjoni ta' Augmentin tipprovdi doża totali kuljum sa' 6000 mg amoxicillin u 600 mg clavulanic acid meta tingħata kif irrakkomandat hawn taħt.
English: • Usual dose - 20 mg/5 mg to 60 mg/15 mg for each kilogram of body weight a day, given in three divided doses.
Maltese: • Doża tas-soltu - 20 mg/5 mg sa 60 mg/15 mg għal kull kilogramma ta' piż tal-ġisem kuljum,
English: Ireland - Augmentin Intravenous Malta - Augmentin Intravenous Netherlands - Augmentin
Maltese: L-Irlanda - Augmentin Intravenous L-Italja - Augmentin Il-Latvja - Augmentin Il-Lussemburgu - Augmentin Malta - Augmentin Intravenous L-Olanda - Augmentin Il-Polonja - Augmentin
English: 250 mg/125 mg film-coated tablets Augmentin tablets are not recommended.
Maltese: Pilloli ta' 250 mg/125 mg miksijin b'rita Pilloli Augmentin mhumiex irrakkomandati.
English: Read all of this leaflet carefully before you
Maltese: DATA TA' META ĠIET RIVEDUTA
English: The pharmacokinetic results that have been obtained for amoxicillin and clavulanic acid following the administration of Augmentin (2 x 1000 mg/62.5 mg single dose) to healthy adults at the start of a meal are presented below:
Maltese: Ir-riżultati farmakokinetiċi li nkisbu għal amoxicillin u clavulanic acid wara l-għoti ta' Augmentin (doża waħda ta' 2 x 1000 mg/62.5 mg) lill-adulti b'saħħithom fil-bidu ta' ikla huma ppreżentati hawn taħt:
English: 500 mg/50 mg powder for solution for injection or infusion Austria - Augmentin intravenös, Clavamox intravenös Belgium - Augmentin
Maltese: Trab ta' 500 mg/50 mg għal soluzzjoni għall-injezzjoni jew għall-infużjoni L-Awstrija - Augmentin intravenös, Clavamox intravenös Il-Belġju - Augmentin
English: 1000 mg/100 mg powder for injection or infusion
Maltese: Trab ta' 1000 mg/100 mg għall-injezzjoni jew għall-infużjoni
English: 250 mg/25 mg powder for solution for injection or infusion This medicinal product contains 4.9 mg (0.1 mmol) of potassium per vial.
Maltese: Trab ta' 250 mg/25 mg għal soluzzjoni għall-injezzjoni jew għall-infużjoni Dan il-prodott mediċinali fih 4.9 mg (0.1 mmol) ta' potassium f'kull kunjett.
English: Clear clinical signs of infection at operation will require a normal course of intravenous or oral therapy post-operatively.
Maltese: Sinjali kliniċi ċari ta' infezzjoni fl-operazzjoni jeħtieġu kors normali ta' kura minn ġol-vini jew mill-ħalq wara l-operazzjoni.
English: 875 mg/125 mg film-coated tablets Austria - Augmentin, Clavamox
Maltese: Pilloli ta' 875 mg/125 mg miksijin b'rita L-Awstrija - Augmentin, Clavamox Il-Belġju - Augmentin
English: { mentin and associated nam es (see Annex I) 50 mg/12.5 mg/ml powder for oral suspension} {Augmentin and associated names (see Annex I) 125 mg/31.25 mg/5 ml powder for oral suspension} {Augmentin and associated names (see Annex I) 250 mg/62.5 mg/5 ml powder for oral suspension} {Augmentin and associated names (see Annex I) 200 mg/28.5 mg/5 ml powder for oral suspension} {Augmentin and associated names (see Annex I) 400 mg/57 mg/5 ml powder for oral suspension (strawberry flavour)} {Augmentin and associated names (see Annex I) 400 mg/57 mg/5 ml powder for oral suspension (mixed fruit flavour)} {Augmentin and associated names (see Annex I) 100 mg/12.5 mg/ml powder for oral suspension} {Augmentin and associated names (see Annex I) 600 mg/42.9 mg/5 ml powder for oral suspension}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 875 mg /125 mg miksijin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 875 mg/125 mg fi qratas għal suspensjoni orali} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 400 mg/57 mg fi qratas għal suspensjoni orali} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab għal suspensjoni orali ta' 200 mg/28.5 mg/5 ml } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab għal suspensjoni orali ta' 400 mg/57 mg/5 ml (togħma ta' frawli)} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab għal suspensjoni orali ta' 400 mg/57 mg/5 ml (togħma ta' frott imħallat)}
English: 500 mg/125 mg film-coated tablets
Maltese: 500 mg/125 mg darba kuljum
English: For children < 40 kg, this formulation of Augmentin provides a maximum daily dose of 1000-2800 mg amoxicillin/143-400 mg clavulanic acid, when administered as recommended below.
Maltese: Għal tfal < 40 kg, din il-formulazzjoni ta' Augmentin tipprovdi doża massima ta' 1000-2800 mg amoxicillin/143400 mg clavulanic acid,kuljum, meta tingħata kif irrakkomandat hawn taħt.
English: Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of a single 500/100 mg or a single 1000/200 mg bolus intravenous injection.
Maltese: Madwar 60 sa 70% ta' amoxicillin u madwar 40 sa 65% ta' clavulanic acid jitneħħew mhux mibdula fl-awrina fl-ewwel 6 sigħat wara lgħoti ta'injezzjoni waħda ta' 500/100 mg jew injezzjoni waħda ta' 1000/200 mg f'daqqa ġol-vini.
English: 125 mg/31.25 mg/5 ml powder for oral suspension Austria - Clavamox
Maltese: Trab għal suspensjoni orali ta' 125 mg/31.25 mg/5 ml L-Awstrija - Clavamox
English: 10 See section 4.3 and 4.4
Maltese: 10 Ara sezzjonijiet 4.3 u 4.4
English: Children aged 6 years and below should preferably be treated with Augmentin suspension or paediatric sachets.
Maltese: Tfal li għandhom 6 snin u anqas għandhom preferibbilment jiġu kkurati bis-suspensjoni jew bil-qratas pedjatriċi ta' Augmentin.
English: • Community acquired pneumonia.
Maltese: • Pulmonite akkwiżita mill-komunità.
English: 1 This presentation of amoxicillin/clavulanic acid is suitable for treatment of Streptococcus pneumoniae that are resistant to penicillin in the approved indications only (see section 4.1).
Maltese: 1 Din il-preżentazzjoni ta' amoxicillin/clavulanic acid hija adattata għall-kura ta' Streptococcus pneumoniae li huwa reżistenti għal penicillin fl-indikazzjonijiet approvati biss (ara sezzjoni 4.1).
English: {Augmentin and associated names (see Annex I) 250 mg/125 mg film-coated tablets} {Augmentin and associated names (see Annex I) 500 mg/125 mg film-coated tablets} {Augmentin and associated names (see Annex I) 875 mg/125 mg film-coated tablets} {Augmentin and associated names (see Annex I) 500 mg/62.5 mg film-coated tablets}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 250 mg/125 mg miksijin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 500 mg/125 mg miksijin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 875 mg/125 mg miksijin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 500 mg/62.5 mg miksijin b'rita}
English: • The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)
Maltese: • Il-patoġeni mistennija u l-probabbiltà tas-suxxettibiltà tagħhom għas-sustanzi antibatteriċi (ara sezzjoni 4.4)
English: 500 mg/100 mg powder for solution for injection or infusion This medicinal product contains 19.6 mg (0.5 mmol) of potassium per vial.
Maltese: Trab ta' 500 mg/100 mg għal soluzzjoni għall-injezzjoni jew għall-infużjoni Dan il-prodott mediċinali fih 19.6 mg (0.5 mmol) ta' potassium f'kull kunjett.
English: 20 mg/5 mg/kg/day to 60 mg/15 mg/kg/day given in three divided doses.
Maltese: 20 mg/5 mg/kg/jum sa 60 mg/15 mg/kg/jum mogħtija bħala doża maqsuma fi tliet darbiet.
English: Au entin.
Maltese: Użu orali.
English: {Augmentin and associated names (see Annex I) 500 mg/62.5 mg film-coated tablets} {Augmentin and associated names (see Annex I) 1000 mg/125 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 250 mg/31.25 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 500 mg/62.5 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 100 mg/12.5 mg/ml powder for oral suspension}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 500 mg/62.5 mg mikisjin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 1000 mg/125 mg fi qratas għal suspensjoni orali} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 250 mg/31.25 mg fi qratas għal suspensjoni orali} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab ta' 500 mg/62.5 mg fi qratas għal suspensjoni orali} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) trab għal suspensjoni orali ta' 100 mg/12.5 mg/ml}
English: For procedures greater than 1 hour in duration, the recommended dose is 1000 mg/100 mg to 2000 mg/200 mg given at induction of anaesthesia, with up to 3 doses of 1000 mg/100 mg in 24 hours.
Maltese: Għal operazzjonijiet li jieħdu aktar minn siegħa, id-doża ta' Augmentin rrakkomandata hija minn 1000 mg/100 mg sa 2000 mg/200 mg mogħtija fil-ħin minn meta jingħata l-anestetiku sa ma tibda loperazzjoni, b'mhux aktar minn 3 dożi ta' 1000 mg/100 mg f'24 siegħa.
English: • Pelvic cavity
Maltese: • L-ispazju tal-pelviċi
English: CrCl: 10-30 ml/min Initial dose of 1000 mg/200 mg and then 500 mg/100 mg given twice daily CrCl < 10 ml /min
Maltese: CrCl: 10-30 ml/min Doża ta' 1000 mg/200 mg fil-bidu mbagħad 500 mg/100 mg mogħtija darbtejn kuljum
English: Uncommon side effect
Maltese: Effetti sekondarji oħra
English: Skin and subcutaneous tissue disorders 8 Skin rash
Maltese: Disturbi fil-ġilda u fit-tessuti ta' taħt il-ġilda8 Raxx fil-ġilda
English: NAME OF THE MEDICINAL PRODUCT Augmentin and associated names (see Annex I) 875 mg/125 mg film-coated tablets [See Annex I - To be completed nationally] Amoxicillin/clavulanic acid
Maltese: Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 875 mg/125 mg miksijin b'rita [Ara Anness I - Biex timtela mill-pajjiż partikolari] Amoxicillin/clavulanic acid
English: 250 mg/125 mg film-coated tablets
Maltese: 250 mg/125 mg darba kuljum
English: The pharmacokinetic results for studies in which amoxicillin/clavulanic acid was administered to groups of healthy volunteers as either 500 mg/100 mg or 1000 mg/200 mg given as a bolus intravenous injection are presented below.
Maltese: Ir-riżulati farmakokinetiċi għal studji li fihom amoxicillin/clavulanic acid ingħataw lill-gruppi ta' voluntiera b'saħħithom bħala 500 mg/100 mg jew 1000 mg/200 mg mogħtija bħala injezzjoni f'daqqa huma ppreżentati hawn taħt.
English: 250 mg/31.25 mg powder for oral suspension in sachets 500 mg/62.5 mg powder for oral suspension in sachets 100 mg/12.5 mg/ml powder for oral suspension Diarrhoea
Maltese: Trab ta' 250 mg/31.25 mg fi qratas għal suspensjoni orali Trab ta' 500 mg/62.5 mg fi qratas għal suspensjoni orali Trab għal suspensjoni orali ta' 100 mg/12.5 mg/ml Dijarea
English: 100 mg/12.5 mg/ml powder for oral suspension France - Augmentin
Maltese: Trab għal suspensjoni orali ta' 100 mg/12.5 mg/ml Franza - Augmentin
English: Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the:
Maltese: Profilassi kontra infezzjonijiet assoċjati ma' operazzjonijiet serji fl-adulti, bħal dawk li jinvolvu:
English: Augmentin 1000 mg/125 mg powder for oral suspension in sachets contains 30 mg of aspartame (E951) per sachet, a source of phenylalanine.
Maltese: Trab ta' 1000 mg/125 mg Augmentin fi qratas għal suspensjoni orali fih 30 mg ta' aspartame (E951) f'kull qartas, li huwa sors ta' phenylalanine.
English: Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of single Augmentin 250 mg/125 mg or 500 mg/125 mg tablets.
Maltese: Madwar 60 sa 70% ta' amoxicillin u madwar 40 sa 65% ta' clavulanic acid jitneħħew mhux mibdula fl-awrina fl-ewwel 6 sigħat wara lgħoti ta' pillola waħda ta' 250 mg/125 mg jew 500 mg/125 mg Augmentin.
English: {Augmentin and associated names (see Annex I) 500 mg/125 mg film-coated tablets} {Augmentin and associated names (see Annex I) 500 mg/125 mg dispersible tablets}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 500 mg/125 mg mikisjin b'rita} {Augmentin u ismijiet assoċjati miegħu (ara Anness I) pilloli ta' 500 mg/125 mg li jixterdu}
English: Slo vak Republic- Augmentin DUO Slo i ven a - Augmentin
Maltese: Ir-Repubblika Ċeka - Augmentin Duo L-Estonja - Augmentin
English: Hepatic events may be severe and in extremely rare circumstances, deaths have been reported.
Maltese: Każijiet epatiċi jistgħu jkunu qawwija u f'ċirkustanżi rari ħafna, ġew irrappurtati mwiet.
English: For procedures greater than 1 hour in duration, the recommended dose of Augmentin is 1000 mg/200 mg to 2000 mg/200 mg given at induction of anaesthesia, with up to 3 doses of 1000 mg/200 mg in 24 hours.
Maltese: Għal operazzjonijiet li jieħdu aktar minn siegħa, id-doża ta' Augmentin rrakkomandata hija bejn 1000 mg/200 mg u 2000 mg/200 mg mogħtija mogħtija fil-ħin minn meta jingħata l-anestetiku sa ma tibda l-operazzjoni, b'mhux aktar minn 3 dożi ta' 1000 mg/200 mg f'24 siegħa.
English: No clinical data are available on doses of Augmentin 4:1 formulations higher than 40 mg/10 mg/kg per day in children under 2 years.
Maltese: L-ebda tagħrif kliniku ma huwa disponibbli għal dożi ta' Augmentin f'formulazzjonijet ta' 4:1 ogħla minn 40 mg/10 mg/kg kuljum fi tfal taħt is-sentejn.
English: 1000 mg/100 mg powder for solution for injection or infusion Water for Injection Ph.Eur.
Maltese: Trab ta' 1000 mg/100 mg għal soluzzjoni għall-injezzjoni jew għall-infużjoni Is-solvent normali huwa Ilma għall-Injezzjonijiet Ph.Eur.
English: • Serious skin reactions: - a widespread rash with blisters and peeling skin, particularly around the mouth, nose eyes and genitals (Stevens-Johnson syndrome), and a more severe form, causing extensive peeling of the skin (more than 30% of the body surface - toxic epiderm necrolysis) - widespread red skin rash with small pus-containing blisters (bullous exfoliative dermatitis) - a red, scaly rash with bumps under the skin and blisters (exanth Contact a doctor immediately if yo
Maltese: • Reazzjonijiet serji fil-ġilda: - raxx mifrux bl-infafet u ġilda titqaxxar, b'mod partikolari madwar il-ħalq, l-imnieħer, lgħajnejn u tqaxxir estensiv tal-ġilda (aktar minn 30% tas-superfiċje tal-ġisem - nekroliżi epidermali tossika) - raxx aħmar mifrux b'infafet żgħar li fihom il-materja (dermatite li titqaxxar b t il-ġilda u nfafet (pustulożi eksantematuża ).
English: • Biliary tract surgery.
Maltese: • L-kirurġija fl-apparat tal-bili.
English: For children < 40 kg, this formulation of Augmentin provides a maximum daily dose of 1600-3000 mg amoxicillin/200-400 mg clavulanic acid, when administered as recommended below.
Maltese: Għal tfal < 40 kg, din il-formulazzjoni ta' Augmentin tipprovdi doża massima ta' 1600-3000 mg amoxicillin/200400 mg clavulanic acid, kuljum meta tingħata kif irrakkomandat hawn taħt.
English: Adults and children  40 kg CrCl: 10-30 ml/min 500 mg/125 mg twice daily CrCl < 10 ml /min
Maltese: CrCl: 10-30 ml/min 500 mg/125 mg darbtejn kuljum CrCl < 10 ml /min
English: 1000 mg/200 mg powder for solution for injection or infusion This medicinal product contains 39.3 mg (1.0 mmol) of potassium per vial.
Maltese: Trab ta' 1000 mg/200 mg għal soluzzjoni għall-injezzjoni jew għall-infużjoni Dan il-prodott mediċinali fih 39.3 mg (1.0 mmol) ta' potassium f'kull kunjett.
English: 125 mg/31.25 mg, 250 mg/62.5 mg powder for oral suspension in sachets 50 mg/12.5 mg/ml, 125 mg/31.25 mg/5 ml, 250 mg/62.5 mg/5 ml powder for oral suspension Diarrhoea
Maltese: Trab ta' 125 mg/31.25 mg, 250 mg/62.5 mg fi qratas għal suspensjoni orali Trab għal suspensjoni orali ta' 50 mg/12.5 mg/ml, 125 mg/31.25 mg/5 ml, 250 mg/62.5 mg/5 ml
English: MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Maltese: Breakpoints tal-MIC għal amoxicillin/clavulanic acid huma dawk tal-Kumitat Ewropew dwar Ittestjar ta' Suxxettibilità Kontra l-Mikrobi (EUCAST).
English: an 40 kg yweight in kilograms.
Maltese: Tfal li jiżnu anqas minn 40 kg
English: Augmentin 250 mg/62.5 mg/5 ml powder for oral suspension contains 2.5 mg of aspartame (E951) per ml, a source of phenylalanine.
Maltese: Trab ta' Augmentin għal suspensjoni orali ta' 250 mg/62.5 mg/5 ml fih 2.5 mg ta' aspartame (E951) f'kull ml, li huwa sors ta' phenylalanine.
English: 00 mg/100 mg, 2000 mg/200 mg powder for injection or infusion dults and children weighing 40 kg and over g/100 mg every 8 to 12 hours.
Maltese: Trab ta' 2000 mg/200 mg għal soluzzjoni għall-infużjoni Augmentin 2000 mg/200 mg għandu jiġi rrikostitwit f'20 ml ta' Ilma għall-Injezzjonijiet Ph.Eur.
English: Estonia - Augmentin
Maltese: L-Estonja - Augmentin
English: • up to 70 mg/10 mg/kg/day given as two divided doses may be considered for some infections (such as otitis media, sinusitis and lower respiratory tract infections).
Maltese: • sa mhux aktar minn 70 mg/10 mg/kg/jum mogħtija bħala doża maqsuma f'darbtejn tista' tiġi kkunsidrata għal xi infezzjonijiet (bħal otite tal-widna tan-nofs, sinożite u infezzjonijiet fin-naħa t'isfel tal-apparat tan-nifs).
English: Augmentin 250 mg/31.25 mg powder for oral suspension in sachets contains 7.5 mg of aspartame (E951) per sachet, a source of phenylalanine.
Maltese: Trab ta' 250 mg/31.25 mg Augmentin fi qratas għal suspensjoni orali fih 7.5 mg ta' aspartame (E951) f'kull qartas, li huwa sors ta' phenylalanine.
English: 125 mg/31.25 mg/5 ml and 250 mg/62.5 mg/5 ml powder for oral suspension
Maltese: Trab ta' 125 mg/31.25 mg u 250 mg/62.5 mg fi qratas għal suspensjoni
English: {Augmentin and associated names (see Annex I) 125 mg/31.25 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 250 mg/62.5 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 400 mg/57 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 250 mg/31.25 mg powder for oral suspension in sachets} {Augmentin and associated names (see Annex I) 500 mg/62.5 mg powder for oral suspension in sachets}
Maltese: {Augmentin u ismijiet assoċjati miegħu (ara Anness I) 125 mg/31.25 mg trab fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) 250 mg/62.5 mg trab fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) 400 mg/57 mg trab fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) 250 mg/31.25 mg trab fi qratas għal suspensjoni orali } {Augmentin u ismijiet assoċjati miegħu (ara Anness I) 500 mg/62.5 mg trab fi qratas għal suspensjoni orali }
English: This Augmentin powder for solution for injection or infusion provides a total daily dose of 3000 mg amoxicillin and 600 mg clavulanic acid when administered as recommended below.
Maltese: Din il-formulazzjoni ta' Augmentin tipprovdi doża totali kuljum ta' 3000 mg amoxicillin u 600 mg clavulanic acid meta tingħata kif irrakkomandat hawn taħt.
English: Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic impairment (see section 4.2).
Maltese: Amoxicillin/clavulanic acid għandu jintuża b'attenzjoni f'pazjenti b'evidenza ta' indeboliment talfwied (ara sezzjoni 4.2).
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients [To be completed nationally] 6.2 Incompatibilities [To be completed nationally] 6.3 Shelf life [To be completed nationally] 6.4 Special precautions for storage [To be completed nationally]
Maltese: [Biex timtela mill-pajjiż partikolari] 6.2 Inkompatibilitajiet [Biex timtela mill-pajjiż partikolari] 6.3 Żmien kemm idum tajjeb il-prodott mediċinali [Biex timtela mill-pajjiż partikolari] 6.4
English: The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (250 mg/125 mg tablets three times daily) was administered in the fasting state to groups of healthy volunteers are presented below.
Maltese: Ir-riżultati farmakokinetiċi għal studju, li fih amoxicillin/clavulanic acid (pilloli ta' 250 mg/125 mg tliet darbiet kuljum) ingħata fi stat ta' sawm lil gruppi ta' voluntiera b'saħħithom huma ppreżentati hawn taħt.